The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 10,714,539 | 1,143,494 | SH | SOLE | 1,143,494 | 0 | 0 | |||
ABEONA THERAPEUTICS INC | COM NEW | 00289Y206 | 3,347,824 | 1,086,956 | SH | SOLE | 1,086,956 | 0 | 0 | |||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 95,384,346 | 5,991,479 | SH | SOLE | 5,991,479 | 0 | 0 | |||
ADICET BIO INC | COM | 007002108 | 31,832,658 | 3,560,700 | SH | SOLE | 3,560,700 | 0 | 0 | |||
ALECTOR INC | COM | 014442107 | 37,441,938 | 4,056,548 | SH | SOLE | 4,056,548 | 0 | 0 | |||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 3,762,392 | 3,948,360 | SH | SOLE | 3,948,360 | 0 | 0 | |||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 28,230,778 | 4,488,200 | SH | SOLE | 4,488,200 | 0 | 0 | |||
ANAPTYSBIO INC | COM | 032724106 | 233,076,534 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | |||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 268,035,217 | 5,183,431 | SH | SOLE | 5,183,431 | 0 | 0 | |||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 6,146,766 | 415,322 | SH | SOLE | 415,322 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 106,848,093 | 3,123,300 | SH | SOLE | 3,123,300 | 0 | 0 | |||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,515,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 29,749,181 | 6,184,861 | SH | SOLE | 6,184,861 | 0 | 0 | |||
AVEO PHARMACEUTICALS INC | COM NEW | 053588307 | 9,724,811 | 650,489 | SH | SOLE | 650,489 | 0 | 0 | |||
BIOATLA INC | COM | 09077B104 | 9,276,622 | 1,124,439 | SH | SOLE | 1,124,439 | 0 | 0 | |||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 507,836 | 282,131 | SH | SOLE | 282,131 | 0 | 0 | |||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 365,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 16,220,065 | 5,232,279 | SH | SOLE | 5,232,279 | 0 | 0 | |||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 18,078,000 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 24,343,813 | 1,330,263 | SH | SOLE | 1,330,263 | 0 | 0 | |||
CULLINAN ONCOLOGY INC | COM | 230031106 | 10,919,651 | 1,035,038 | SH | SOLE | 1,035,038 | 0 | 0 | |||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 9,079,105 | 884,903 | SH | SOLE | 884,903 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 26,916,431 | 2,322,384 | SH | SOLE | 2,322,384 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 31,229,154 | 3,493,194 | SH | SOLE | 3,493,194 | 0 | 0 | |||
ERASCA INC | COM | 29479A108 | 2,924,081 | 678,441 | SH | SOLE | 678,441 | 0 | 0 | |||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 665,993 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | |||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,998,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
GALAPAGOS NV | SPON ADR | 36315X101 | 165,569,797 | 3,730,730 | SH | SOLE | 3,730,730 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 9,748,987 | 4,028,507 | SH | SOLE | 4,028,507 | 0 | 0 | |||
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 7,689,365 | 3,343,202 | SH | SOLE | 3,343,202 | 0 | 0 | |||
GRAPHITE BIO INC | COM | 38870X104 | 18,964,159 | 5,712,096 | SH | SOLE | 5,712,096 | 0 | 0 | |||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,992,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
HOOKIPA PHARMA INC | COM | 43906K100 | 2,003,526 | 2,473,489 | SH | SOLE | 2,473,489 | 0 | 0 | |||
IMMATICS N.V | SHS | N44445109 | 6,471,530 | 743,000 | SH | SOLE | 743,000 | 0 | 0 | |||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 790,574 | 40,480 | SH | SOLE | 40,480 | 0 | 0 | |||
JANUX THERAPEUTICS INC | COM | 47103J105 | 18,718,771 | 1,421,319 | SH | SOLE | 1,421,319 | 0 | 0 | |||
KRONOS BIO INC | COM | 50107A104 | 529,384 | 326,780 | SH | SOLE | 326,780 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 82,382,184 | 6,638,371 | SH | SOLE | 6,638,371 | 0 | 0 | |||
KYMERA THERAPEUTICS INC | COM | 501575104 | 19,870,481 | 796,093 | SH | SOLE | 796,093 | 0 | 0 | |||
MACROGENICS INC | COM | 556099109 | 7,498,123 | 1,117,455 | SH | SOLE | 1,117,455 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 105,704,391 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 ADDED | N62509117 | 726,649 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | |||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 32,306,300 | 6,435,518 | SH | SOLE | 6,435,518 | 0 | 0 | |||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 1,849,599 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | |||
NUVATION BIO INC | COM CL A | 67080N101 | 26,681,363 | 13,896,543 | SH | SOLE | 13,896,543 | 0 | 0 | |||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 20,132,421 | 3,418,068 | SH | SOLE | 3,418,068 | 0 | 0 | |||
OVID THERAPEUTICS INC | COM | 690469101 | 11,378,364 | 6,117,400 | SH | SOLE | 6,117,400 | 0 | 0 | |||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 14,045,000 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | |||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 3,773,071 | 1,585,324 | SH | SOLE | 1,585,324 | 0 | 0 | |||
PRECISION BIOSCIENCES INC | COM | 74019P108 | 5,992,805 | 5,035,971 | SH | SOLE | 5,035,971 | 0 | 0 | |||
PRIME MEDICINE INC | COM ADDED | 74168J101 | 11,148,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 697,952,870 | 11,584,280 | SH | SOLE | 11,584,280 | 0 | 0 | |||
RELAY THERAPEUTICS INC | COM | 75943R102 | 62,207,531 | 4,163,824 | SH | SOLE | 4,163,824 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 106,206,972 | 4,458,731 | SH | SOLE | 4,458,731 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 388,669,120 | 2,999,453 | SH | SOLE | 2,999,453 | 0 | 0 | |||
SELECTA BIOSCIENCES INC | COM | 816212104 | 3,955,000 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 90,000,010 | 3,460,208 | SH | SOLE | 3,460,208 | 0 | 0 | |||
SURFACE ONCOLOGY INC | COM | 86877M209 | 3,218,265 | 3,924,713 | SH | SOLE | 3,924,713 | 0 | 0 | |||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 38,792 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 30,460,252 | 4,201,414 | SH | SOLE | 4,201,414 | 0 | 0 | |||
TEMPEST THERAPEUTICS INC | COM | 87978U108 | 1,185,958 | 1,031,268 | SH | SOLE | 1,031,268 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 13,116,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 28,998,833 | 4,753,907 | SH | SOLE | 4,753,907 | 0 | 0 | |||
XENCOR INC | COM | 98401F105 | 137,556,717 | 5,282,516 | SH | SOLE | 5,282,516 | 0 | 0 | |||
ZAI LAB LTD | ADR | 98887Q104 | 66,240,960 | 2,157,686 | SH | SOLE | 2,157,686 | 0 | 0 | |||
ZYMEWORKS DEL INC | COM ADDED | 98985Y108 | 59,488,984 | 7,568,573 | SH | SOLE | 7,568,573 | 0 | 0 |